THURSDAY, Oct. 9, 2025 -- The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical...
Vous n'êtes pas connecté
(StatePoint) Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH), a rare lung disease that can be fatal if left untreated. ......
THURSDAY, Oct. 9, 2025 -- The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical...
A new study has shown that a drug called sotatercept could make a big difference in treating a serious lung disease known as pulmonary arterial...
Sotatercept drug may foster lung health in severe pulmonary hypertension patients, controlling pathological spread and hospitalization risk.
Sotatercept drug may foster lung health in severe pulmonary hypertension patients, controlling pathological spread and hospitalization risk.
When breathing becomes a daily battle, even the simplest acts can feel exhausting. Now, a new study has found the key to easing chronic breathlessness...
When breathing becomes a daily battle, even the simplest acts can feel exhausting. Now, a new study has found the key to easing chronic breathlessness...
Katie Mitchell had procedure at 15 after being diagnosed with Eisenmenger syndrome, a rare congenital disease
MONDAY, Oct. 6, 2025 — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the...
MONDAY, Oct. 6, 2025 — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the...
Technological Advancements in Diagnosis and Treatment Transforming Interstitial Lung Disease Care The Global Interstitial Lung Disease (ILD) Treatment...